发明名称 METHODS FOR TREATING EYE DISORDERS USING OPIOID RECEPTOR ANTAGONISTS
摘要 The present invention discloses methods for treating eye disorders using opioid receptor antagonists. The methods include the step of administering an effective amount of a topically-administered opioid receptor antagonist in the absence of moxifloxacin. Preferably, the topically-administered opioid receptor antagonist is formulated as a solution. Preferably, the topically-administered opioid receptor antagonist is at least one agent selected from the group consisting of: naltrexone, naloxone, nalmefene, and a pharmaceutically-acceptable salt thereof. Preferably, the effective amount corresponds to a concentration of at least about 10−7 molarity. Preferably, the effective amount is based on a treatment administration of at least once every other day.
申请公布号 US2014213605(A1) 申请公布日期 2014.07.31
申请号 US201313792735 申请日期 2013.03.11
申请人 REMEDEYE INC 发明人 Rogosnitzky Moshe
分类号 A61K31/485 主分类号 A61K31/485
代理机构 代理人
主权项 1. A method for treating anterior segment eye disorders using opioid receptor antagonists, the method comprising the step of: (a) administering an effective amount of a topically-administered opioid receptor antagonist, in the absence of moxifloxacin, for treating eye disorders affecting the anterior segment of the eye, wherein said topically-administered opioid receptor antagonist is at least one agent selected from the group consisting of: naltrexone, naloxone, nalmefene, and a pharmaceutically-acceptable salt thereof.
地址 New Castle DE US